Millions have rolled up their sleeves to take the COVID-19 vaccination because the jab promises protection against the notorious pathogen. However, millions more remain hesitant. Now, officials are pushing a new incentive: freedom.
A growing number of universities now require that students get vaccinated before they return to campus. Airlines and workplaces are devising apps that allow entry based on inoculation status. And several countries are either set to unveil, or have already rolled out, a vaccine passport program. Details in each system may vary, but they all involve lifting restrictions for those who take the COVID-19 vaccine, and maintaining restrictions for those who haven’t.
Most governments haven’t tried to mandate the vaccine—a gene therapy released under emergency use authorization in the United States that is still undergoing clinical trials. And even as they promote the idea of vaccine passports, officials maintain that the decision to get the shot is still a matter of personal choice. But, after a year of social restrictions, the promise of any measure of freedom certainly makes taking the jab a bit more tempting.
Critics call such programs manipulative and discriminatory. But supporters say these measures are a vital step toward easing the world safely back to normalcy.
“Vaccines can help us return to the things we love about life, so we encourage every American to get vaccinated as soon as they have the opportunity,” CDC Director Dr. Rochelle Walensky said in the statement.
The reasoning behind these vaccine-for-freedom programs is that vaccinated individuals are less likely to spread or contract the disease, and therefore deserve to have less restrictions than those at greater risk of transmitting a potentially deadly virus.
Community immunity is the goal, and health officials say the vaccinated earn their freedom by contributing to this goal through their antibodies. The presence of these immune cells are proof that vaccinated individuals possess protection that the unvaccinated do not.
But vaccination isn’t the only road to antibody protection. Just like with other viral infections, people who catch COVID-19 can develop some immunity to the disease. And when you consider the number of people who have contracted COVID-19 and recovered, many have likely earned their antibodies naturally.
So if the goal is disease defense, doesn’t natural immunity deserve a pass, too?
But natural immunity against COVID-19 has demonstrated promise as well.
Proving Immunity
There has been talk of granting immunity certificates to those who recovered from COVID-19 that would function in much the same way that vaccine passports work. However, when it comes to handing out freedom to the naturally immune folks, there are concerns to consider: How strong is their protection and how long will it last?Another problem is that there is no standard to measure natural antibody protection.
“With regard to developing a satisfactory passporting test, no standard antibody assay yet exists and there are no validated antibody concentrations that correlate with or signify protection, either against illness or infectivity,” the report stated.
“As such, the World Health Organization (WHO) has advised against the use of immunity certificates at this time as they have the potential to increase the risk of continued transmission,” the report stated.
Conditions for Freedom
The WHO report lists three conditions that would need to be met for immunity certification to be a reasonable policy approach. Two require scientists to establish antibody standards.First, what are reliable indicators for protection? And second, since declining immunity is common in coronavirus infections, a minimum length of immunity must be established. This duration must be “monitored over time so as to understand whether and when certificate holders need to reassess their immunity status and, possibly, renew their certificate.”
The third condition requires the availability of accurate tests to identify immune individuals. However, the technology currently available is time-consuming, and requires expensive lab analysis, making widespread antibody testing not so feasible.
“I think this is something that has huge privacy implications and is not necessary to do,” DeSantis said. “[Vaccination] is something we want available for all, but mandated for none.”